My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Xencor, Inc. - Common Stock (NQ:XNCR)

15.57 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Nov 20, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Xencor, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Xencor and Bristol Myers Squibb Enter License Agreement for Use of Xtend™ XmAb® Technology in SARS-CoV-2 Neutralizing Monoclonal Antibody Combination for the Treatment of COVID-19

May 25, 2021

From Xencor, Inc.

Via Business Wire

Xencor to Present at the 2021 RBC Capital Markets Global Healthcare Virtual Conference

May 12, 2021

From Xencor, Inc.

Via Business Wire

Xencor Inc (XNCR) Q1 2021 Earnings Call Transcript ↗

May 06, 2021

XNCR earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

Xencor's Earnings: A Preview ↗

May 04, 2021

On Wednesday, May 05, Xencor (NASDAQ:XNCR) will release its latest earnings report. Check out Benzinga's preview to understand the implications. What Are Earnings, Net Income,...

Via Benzinga

Xencor Reports First Quarter 2021 Financial Results

May 05, 2021

From Xencor, Inc.

Via Business Wire

Xencor Doses First Subject in Phase 1 Study of XmAb®564, an Engineered IL-2 Cytokine in Development for Autoimmune Diseases

April 28, 2021

From Xencor, Inc.

Via Business Wire

Xencor to Host First Quarter 2021 Financial Results Webcast and Conference Call on May 5, 2021

April 28, 2021

From Xencor, Inc.

Via Business Wire

Xencor Presents Data from Multiple Preclinical XmAb® Bispecific Antibody and Cytokine Programs at the AACR Annual Meeting 2021

April 10, 2021

From Xencor, Inc.

Via Business Wire

The Daily Biotech Pulse: Q1 Beat From Johnson & Johnson, KalVista Study Placed On Hold, European Label Expansion For GW Pharma's Epidiolex ↗

April 20, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 15) Alexion Pharmaceuticals,...

Via Benzinga

The Daily Biotech Pulse: Merck Shelves 2 COVID-19 Studies, Bristol-Myers Squibb Gets European Regulatory Nod, InspireMD's Reverse Split ↗

April 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 14) 10x Genomics, Inc. (NASDAQ...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.